Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v13-EN | Version v7-EN | |
---|---|---|
Language | English | English |
Date Updated | 2021-04-30 | 2020-12-01 |
Drug Identification Number | 02474093 | 02474093 |
Brand name | REKOVELLE | REKOVELLE |
Common or Proper name | follitropin delta injection (cartridge) | follitropin delta injection (cartridge) |
Company Name | FERRING INC | FERRING INC |
Ingredients | FOLLITROPIN DELTA | FOLLITROPIN DELTA |
Strength(s) | 12MCG | 12MCG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
Packaging size | 1 cartridge with 1 needle | 1 cartridge with 1 needle |
ATC code | G03GA | G03GA |
ATC description | ||
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | 2019-12-04 | 2019-12-04 |
Actual start date | 2019-12-04 | 2019-12-04 |
Estimated end date | Unknown | Unknown |
Actual end date | 2021-04-29 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | REKOVELLE cartridges are currently in shortage. REKOVELLE prefilled pens are alternative products. Please contact your healthcare professional. | REKOVELLE cartridges are currently in shortage. REKOVELLE prefilled pens are alternative products. Please contact your healthcare professional. |
Health Canada comments |